Postpartum hemorrhage: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
==Background==
==Background==
*Uterine atony is responsible for 80% of postpartum hemorrhage cases


===Causes===
===Causes===
*[[Uterine atony]]
*[[Uterine atony]] (responsible for 80% of cases)
*Retained placental tissue
*Retained placental tissue
*Lower genital tract lacerations
*Lower genital tract lacerations
Line 9: Line 8:
*Uterine inversion
*Uterine inversion
*Underlying [[coagulopathy|coagulation abnormalities]]
*Underlying [[coagulopathy|coagulation abnormalities]]
==Clinical Features==


==Differential Diagnosis==
==Differential Diagnosis==
Line 29: Line 30:
#Examine for tears under good lighting and suction
#Examine for tears under good lighting and suction
#Treat underlying cause - 4T's: '''Tone, Trauma, Tissue, Thrombosis'''
#Treat underlying cause - 4T's: '''Tone, Trauma, Tissue, Thrombosis'''
===Tone===
===Tone===
''[[Uterine atony]] (boggy uterus)''
''[[Uterine atony]] (boggy uterus)''
Line 51: Line 53:
*#Consider nitroglycerine IV 50 mcg, then up to x4 additional doses q3-5 min to relax uterus
*#Consider nitroglycerine IV 50 mcg, then up to x4 additional doses q3-5 min to relax uterus
*#After replacement, oxytocin infusion with 40 units in 1 L of NS at 200 ml/hr
*#After replacement, oxytocin infusion with 40 units in 1 L of NS at 200 ml/hr
===Tissue===
===Tissue===
''Retained placental tissue''
''Retained placental tissue''
Line 57: Line 60:
#Manual removal
#Manual removal
#Curettage
#Curettage
===Thrombin===
===Thrombin===
''Reverse any coagulopathies''
''Reverse any coagulopathies''
#Labs - platelets, coags, fibrinogen, d-dimer
#Labs - platelets, coags, fibrinogen, d-dimer
#Replace appropriate blood components
#Replace appropriate blood components
==Disposition==
Admit


==See Also==
==See Also==

Revision as of 04:41, 9 August 2015

Background

Causes

Clinical Features

Differential Diagnosis

3rd Trimester/Postpartum Emergencies

Diagnosis

Immediate

  • Defined as loss of >500 mL blood after spontaneous vaginal delivery
  • Within 24 hrs following delivery

Delayed

  • Uterine subinvolution
  • von Willebrand disease
  • Retained placenta

Management

  1. Fluid resuscitation
  2. Consider Blood Products for Hemodynamic Instability
  3. Evaluate placenta for retained products
  4. Examine for tears under good lighting and suction
  5. Treat underlying cause - 4T's: Tone, Trauma, Tissue, Thrombosis

Tone

Uterine atony (boggy uterus)

  1. Bimanual Massage
  2. Oxytocin (Pitocin)
    1. 1st line and most important drug - Oxytocin 80 units in 500 cc NS bag, run it wide open[1]
    2. OR 20 MILLIunits/min IV after placenta delivery (rapid administration may cause hypotension)
    3. OR 10 units IM if no IV
  3. Misoprostol (Cytotec) 600mcg SL or 1000 mcg rectally
  4. Methylergonovine (Methergine) 0.2mg IM q2-4 hrs (relative contraindication in pts with HTN or Preeclampsia - may consider in severely unstable BP)
  5. Carboprost (Hemabate) 250mcg IM q15 min (avoid in pts with asthma)
  6. Bakri balloon placement, fill with warm 500 ml NS (or large/multiple Foleys or pack) - use US to place to top of fundus and ensure no retained placenta

Trauma

  • Genital tract tear
    1. Suture lacerations
    2. Drain hematomas >3 cm
  • Uterine inversion
    1. Manually replace placenta OR do not remove placenta until uterus has been replaced:
    2. Place hand inside the vagina and push the fundus cephalad along long axis of vagina
    3. Prompt replacement important since cervix contracts over time creating a constriction ring
    4. Consider nitroglycerine IV 50 mcg, then up to x4 additional doses q3-5 min to relax uterus
    5. After replacement, oxytocin infusion with 40 units in 1 L of NS at 200 ml/hr

Tissue

Retained placental tissue

  1. Pelvic exam may be normal other than blood
  2. Detect with US
  3. Manual removal
  4. Curettage

Thrombin

Reverse any coagulopathies

  1. Labs - platelets, coags, fibrinogen, d-dimer
  2. Replace appropriate blood components

Disposition

Admit

See Also

References

  1. Tita AT et al. Higher-dose oxytocin and hemorrhage after vaginal delivery: a randomized controlled trial. Obstet Gynecol. 2012 Feb;119(2 Pt 1):293-300.